The COVID-19 Pandemic – Webinars and Online Events

Recent technical advances allow investigators to analyze clinical samples with robust high-throughput proteomic workflows, creating an opportunity to analyze large numbers of patient samples during the COVID-19 pandemic.

As we all know, current global research efforts are focused on understanding the SARS-CoV-2 virus. Developing vaccines and therapies to combat the virus has become a priority, laboratories are addressing research questions at key stages in viral infectivity workflows.

This webinar will provide a behind the scenes vignette of how to build leadership in the vaccine sciences, an overview of the vaccine development process and highlight a case study of how a COVID-19 vaccine, suitable for global access, was developed and is currently advancing towards achieving emergency use authorization for distribution and global access.

Vaccination has proven to be the most successful form of disease prevention available today. However, infectious diseases still account for large numbers of the yearly reported casualties, especially in developing countries.

Research focused on SARS-CoV-2 has become a primary focus in genomic and molecular biology fields. The availability of accurate, efficient, and consistent analytical tools, including new methods for screening and studying virus-host interactions, is critical.

Surveillance analysis of potentially pathogenic microbes found in shared public resources is an important component of research aimed at understanding, preparing for, and protecting communities from potential widespread infection and transmission of infectious diseases.

Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least two distinct types of cytokine signatures induced by SARS-CoV-2 infection.

In this webinar, Associate Professor Teresa Lambe will describe the development, testing and immune readout after vaccination with ChAdOx1 nCOV-19/AZD1222. The session also offers a unique opportunity to interact with Professor Lambe through a live Q&A session following her presentation.

Vanderbilt University Medical Center researchers Robert Carnahan and Pavlo Gilchuk are attempting to compress the timeline for therapeutic antibody development, by integrating a series of advances in single-cell messenger RNA sequence analysis, bioinformatics, synthetic biology and high-throughput functional analysis.

In this webinar there will be two speakers discussing High-Throughput Functional Evaluation of Melanocortin Compounds at the MC4R-Kir7.1 Complex: Biased Signaling at the Melanocortin 4 Receptor and CiPA Based Evaluation of Proarrhythmia